Due to health issues, this site is no longer maintained and will be shut down shortly. |
Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.
$270.51 +0.48 (0.18%)
As of 03/27/2023 14:08:30 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.